Woman Man
- | Country :
- Bulgaria
- Mexico
- United Kingdom
- The 8 others...
- | organs : -
- | Specialty : -
Extract
This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naïve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle
Inclusion criteria
- NSCLC